Repare Therapeutics Inc
NASDAQ:RPTX
Repare Therapeutics Inc
Interest Income Expense
Repare Therapeutics Inc
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Interest Income Expense
$13.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Zymeworks Inc
NYSE:ZYME
|
Interest Income Expense
$18.5m
|
CAGR 3-Years
36%
|
CAGR 5-Years
47%
|
CAGR 10-Years
N/A
|
|
Theratechnologies Inc
TSX:TH
|
Interest Income Expense
-$8.1m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Interest Income Expense
$4.1m
|
CAGR 3-Years
131%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Interest Income Expense
$13.7m
|
CAGR 3-Years
157%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
34%
|
|
Spectral Medical Inc
TSX:EDT
|
Interest Income Expense
-CA$3.2m
|
CAGR 3-Years
-373%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Repare Therapeutics Inc's Interest Income Expense?
Interest Income Expense
13.2m
USD
Based on the financial report for Dec 31, 2023, Repare Therapeutics Inc's Interest Income Expense amounts to 13.2m USD.
What is Repare Therapeutics Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 1Y
123%
Over the last year, the Interest Income Expense growth was 123%.